The short and long-term functional effects of incontinence and erectile dysfunction following robot-assisted radical prostatectomy (RARP) are well known, and were integrally weighed in the United States Preventative Services Task Force evaluation of prostate specific antigen-(PSA) based prostate cancer screening1,2. This evidence concerns the gene KLK3 and erectile dysfunction.